Dual Hepatitis Screening

Hepatitis C Virus (HCV) Antibody/Hepatitis B Virus (HBV) Antigen Combo Rapid Test

Simultaneous detection of HCV antibodies and HBV antigens in human whole blood.

CE Certified
ISO 13485
Main image of Hepatitis C Virus (HCV) Antibody/Hepatitis B Virus (HBV) Antigen Combo Rapid Test

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Rapid Results

Results available in just 10-15 minutes for timely diagnosis.

Single Sample

Detects both HCV and HBV from a single whole blood sample.

Cost-Effective

Reduces time and cost associated with separate individual testing.

Product Overview

The HCV Antibody/HBV Antigen Combo Rapid Test is a qualitative in-vitro diagnostic device designed for the simultaneous detection of antibodies to HCV and antigens to HBV in human whole blood samples. This rapid test provides a convenient and efficient method for initial screening of individuals suspected of having Hepatitis C or B infection. Early detection of Hepatitis C and B is crucial for preventing the development of severe liver disease, cirrhosis, and liver cancer.

Technical Specifications

Detection Target HCV Antibodies, HBV Antigens
Sample Type Whole Blood
Methodology Immunochromatography
Detection Range Qualitative (Positive/Negative)
Reaction Time 10-15 minutes
Storage Conditions 2-30u00b0C
Shelf Life 24 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect whole blood sample.
  2. Apply sample to the test device.
  3. Wait 10-15 minutes.
  4. Read and interpret the results.

Result Interpretation

Positive Result
Positive: The presence of lines for HCV Ab and/or HBV Ag indicates a positive result for the respective infection(s).
Negative Result
Negative: The absence of lines for HCV Ab and HBV Ag indicates a negative result.
Invalid Result
Invalid: If no lines appear or the control line is absent, the test is invalid and should be repeated.

Frequently Asked Questions

This combo test simultaneously screens for Hepatitis C antibodies and Hepatitis B antigens, allowing for a cost-effective and efficient initial screening for both viral infections.

Early detection of HCV and HBV through this test enables timely diagnosis, treatment, and lifestyle interventions, reducing the risk of long-term complications such as cirrhosis and liver cancer.

Yes, the simplicity and rapid results of this test make it especially suitable for use in resource-limited settings where access to specialized laboratory equipment may be limited.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor